R&D expense · 2012–2025
Tandem Diabetes Care R&D expense
$193M−2.9% · FY2025
Tandem Diabetes Care (TNDM) reported $193M in R&D expense for fiscal 2025, −2.9% year on year.
| Fiscal year | R&D expense | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $193M | −2.9% | Open → |
| FY20242024-12-31 | $199M | +17.2% | Open → |
| FY20232023-12-31 | $170M | +22.0% | Open → |
| FY20222022-12-31 | $139M | +51.1% | Open → |
| FY20212021-12-31 | $92.1M | +44.8% | Open → |
| FY20202020-12-31 | $63.6M | +40.7% | Open → |
| FY20192019-12-31 | $45.2M | +54.6% | Open → |
| FY20182018-12-31 | $29.2M | +41.5% | Open → |
| FY20172017-12-31 | $20.7M | +9.8% | Open → |
| FY20162016-12-31 | $18.8M | +10.9% | Open → |
| FY20152015-12-31 | $17.0M | +7.4% | Open → |
| FY20142014-12-31 | $15.8M | +42.5% | Open → |
| FY20132013-12-31 | $11.1M | +23.0% | Open → |
| FY20122012-12-31 | $9.0M | — | Open → |
R&D expense — Research and development expense is what the company charged to R&D in the income statement for the year. Most companies report no R&D at all — the line is absent rather than zero — so this ranking covers the roughly 40% of filers that do.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2012–2025 compound annual growth +26.6%
R&D expense at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Tandem Diabetes Care R&D expense |url=https://companiesranked.com/en/company/tandem-diabetes-care/research-and-development-expense |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Tandem Diabetes Care R&D expense. CompaniesRanked. https://companiesranked.com/en/company/tandem-diabetes-care/research-and-development-expenseBibTeX
@misc{companiesranked-en-company-tandem-diabetes-care-research-and-development-expense-2026,
author = {{CompaniesRanked}},
title = {{Tandem Diabetes Care R\&D expense}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/tandem-diabetes-care/research-and-development-expense}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001438133-26-000010 · February 19, 2026
{{cite web |title=Tandem Diabetes Care R&D expense — 10-K (0001438133-26-000010) |url=https://www.sec.gov/Archives/edgar/data/1438133/000143813326000010/tndm-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-19}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.